{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:14Z","timestamp":1792787894671,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai Science and Technology Commission Project","award":["grant number 19441904300"],"award-info":[{"award-number":["grant number 19441904300"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["grant number 81871267"],"award-info":[{"award-number":["grant number 81871267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Shenkang Hospital Development Center","award":["grant number SHDC2020CR3007A"],"award-info":[{"award-number":["grant number SHDC2020CR3007A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neutrophil CD64 (nCD64) index has been widely studied as an indication of bacteria-infected diseases, but the exact usage of nCD64 index in monitoring infections remains debated. So this study aims to investigate the functionality of nCD64 index in tracking infections\u2019 progression and evaluating antibiotic therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>160 participants (36 healthy controls, 34 culture-negative patients, 56 respiratory tract infected patients, and 34 bloodstream infected patients) were recruited and divided into groups. Data on nCD64 index, T lymphocyte subsets, and conventional indicators, including white blood cell count, neutrophil to lymphocyte ratio, procalcitonin, and C-reactive protein, were tested and compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Bacteria-infected patients had significantly higher nCD64 indexes (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), especially patients with both bloodstream and respiratory tract infections. The nCD64 index could identify infected patients from culture-negative patients or controls, which conventional indicators cannot achieve. We followed up with 24 infected patients and found that their nCD64 indexes were promptly down-regulated after effective antibiotic therapy (3.16\u2009\u00b1\u20093.01 vs. 1.20\u2009\u00b1\u20091.47,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The nCD64 index is a sensitive indicator for clinical diagnosis of bacterial infection, especially in monitoring infection and evaluating antibiotics\u2019 efficacy. Therefore, nCD64 has the potential to improve diagnostic accuracy and provide rapid feedback on monitoring disease progression in infected patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-022-07725-4","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T03:04:13Z","timestamp":1669604653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Neutrophil CD64 index as a superior indicator for diagnosing, monitoring bacterial infection, and evaluating antibiotic therapy: a case control study"],"prefix":"10.1186","volume":"22","author":[{"given":"Yanting","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"issue":"4","key":"7725_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1021\/acsinfecdis.0c00890","volume":"7","author":"C Deusenbery","year":"2021","unstructured":"Deusenbery C, Wang Y, Shukla A. Recent innovations in bacterial infection detection and treatment. ACS Infect Dis. 2021;7(4):695\u2013720.","journal-title":"ACS Infect Dis"},{"key":"7725_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","volume":"51","author":"MI Hutchings","year":"2019","unstructured":"Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbiol. 2019;51:72\u201380.","journal-title":"Curr Opin Microbiol"},{"issue":"3","key":"7725_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/21505594.2016.1159366","volume":"7","author":"M Akova","year":"2016","unstructured":"Akova M. Epidemiology of antimicrobial resistance in bloodstream infections. Virulence. 2016;7(3):252\u201366.","journal-title":"Virulence"},{"key":"7725_CR4","volume-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization; 2014."},{"issue":"7","key":"7725_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16(7):819\u201327.","journal-title":"Lancet Infect Dis"},{"key":"7725_CR6","doi-asserted-by":"crossref","unstructured":"Cong S, Ma T, Di X, Tian C, Zhao M, Wang K: Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis. Meta-Analysis 2021, 21(1):384.","DOI":"10.1186\/s12879-021-06064-0"},{"issue":"1","key":"7725_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2015.09.007","volume":"72","author":"J ten Oever","year":"2016","unstructured":"ten Oever J, Netea MG, Kullberg BJ. Utility of immune response-derived biomarkers in the differential diagnosis of inflammatory disorders. J Infect. 2016;72(1):1\u201318.","journal-title":"J Infect"},{"issue":"7","key":"7725_CR8","doi-asserted-by":"publisher","first-page":"e6783","DOI":"10.1590\/1414-431x20176783","volume":"51","author":"JH Tang","year":"2018","unstructured":"Tang JH, Gao DP, Zou PF. Comparison of serum PCT and CRP levels in patients infected by different pathogenic microorganisms: a systematic review and meta-analysis. Braz J Med Bio Res. 2018;51(7):e6783.","journal-title":"Braz J Med Bio Res"},{"key":"7725_CR9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.biopha.2017.11.149","volume":"96","author":"MY Memar","year":"2017","unstructured":"Memar MY, Varshochi M, Shokouhi B, Asgharzadeh M, Kafil HS. Procalcitonin: The marker of pediatric bacterial infection. Biomed Pharmacother. 2017;96:936\u201343.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"7725_CR10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10067-019-04518-0","volume":"38","author":"BQ Hu","year":"2019","unstructured":"Hu BQ, Yang Y, Zhao CJ, Liu DF, Kuang F, Zhang LJ, Yu X. Accuracy of neutrophil CD64 expression in diagnosing infection in patients with autoimmune diseases: a meta-analysis. Clin Rheumatol. 2019;38(5):1319\u201328.","journal-title":"Clin Rheumatol"},{"key":"7725_CR11","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.3389\/fimmu.2018.02171","volume":"9","author":"E Mortaz","year":"2018","unstructured":"Mortaz E, Alipoor SD, Adcock IM, Mumby S, Koenderman L. Update on neutrophil function in severe inflammation. Front Immunol. 2018;9:2171.","journal-title":"Front Immunol"},{"issue":"5","key":"7725_CR12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/JLB.4AB0417-152RRR","volume":"103","author":"A Garc\u00eda-Salido","year":"2018","unstructured":"Garc\u00eda-Salido A, Serrano-Gonz\u00e1lez A, Casado-Flores J, Sierra-Colomina M, de Azagra-Garde AM, Garc\u00eda-Teresa M, Melen GJ, Ram\u00edrez-Orellana M. CD64 on monocytes and granulocytes in severe acute bronchiolitis: Pilot study on its usefulness as a bacterial infection biomarker. J Leukoc Biol. 2018;103(5):965\u201371.","journal-title":"J Leukoc Biol"},{"issue":"15\u201316","key":"7725_CR13","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s00508-020-01747-1","volume":"133","author":"A Vujaklija Brajkovi\u0107","year":"2021","unstructured":"Vujaklija Brajkovi\u0107 A, Ko\u0161uta I, Tomek D, Rora M, Babel J, Rogi\u0107 D, Lon\u010dar Vran\u010di\u0107 A, Radoni\u0107 R. Utility of procalcitonin in a medical intensive care unit in Croatia. Wien Klin Wochenschr. 2021;133(15\u201316):832\u20139.","journal-title":"Wien Klin Wochenschr"},{"issue":"2\u20133","key":"7725_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0161-5890(01)00042-6","volume":"38","author":"JE Volanakis","year":"2001","unstructured":"Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol. 2001;38(2\u20133):189\u201397.","journal-title":"Mol Immunol"},{"issue":"5","key":"7725_CR15","doi-asserted-by":"publisher","first-page":"e002396","DOI":"10.1136\/bmjgh-2020-002396","volume":"5","author":"C Escadafal","year":"2020","unstructured":"Escadafal C, Incardona S, Fernandez-Carballo BL, Dittrich S. The good and the bad: using C reactive protein to distinguish bacterial from non-bacterial infection among febrile patients in low-resource settings. BMJ Glob Health. 2020;5(5):e002396.","journal-title":"BMJ Glob Health"},{"key":"7725_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12879-015-1272-6","volume":"15","author":"Y Lubell","year":"2015","unstructured":"Lubell Y, Blacksell SD, Dunachie S, Tanganuchitcharnchai A, Althaus T, Watthanaworawit W, Paris DH, Mayxay M, Peto TJ, Dondorp AM, et al. Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia. BMC Infect Dis. 2015;15:511.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"7725_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12026-013-8384-0","volume":"56","author":"W Ansar","year":"2013","unstructured":"Ansar W, Ghosh S. C-reactive protein and the biology of disease. Immunol Res. 2013;56(1):131\u201342.","journal-title":"Immunol Res"},{"key":"7725_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.micpath.2017.03.042","volume":"107","author":"N Chauhan","year":"2017","unstructured":"Chauhan N, Tiwari S, Jain U. Potential biomarkers for effective screening of neonatal sepsis infections: an overview. Microb Pathog. 2017;107:234\u201342.","journal-title":"Microb Pathog"},{"issue":"6","key":"7725_CR19","doi-asserted-by":"publisher","first-page":"R291","DOI":"10.1186\/cc13157","volume":"17","author":"A Prkno","year":"2013","unstructured":"Prkno A, Wacker C, Brunkhorst FM, Schlattmann P. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock\u2013a systematic review and meta-analysis. Crit Care. 2013;17(6):R291.","journal-title":"Crit Care"},{"issue":"3","key":"7725_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.7150\/ijms.39367","volume":"17","author":"R Paudel","year":"2020","unstructured":"Paudel R, Dogra P, Montgomery-Yates AA, Coz Yataco A. Procalcitonin: a promising tool or just another overhyped test? Int J Med Sci. 2020;17(3):332\u20137.","journal-title":"Int J Med Sci"},{"key":"7725_CR21","doi-asserted-by":"crossref","unstructured":"Hoffmann JJ. Neutrophil\u00a0 CD64: a diagnostic marker for infection and sepsis. Clin Chem Lab Med 47(8):903\u201316.","DOI":"10.1515\/CCLM.2009.224"},{"issue":"1","key":"7725_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1542\/peds.2007-1308","volume":"121","author":"V Bhandari","year":"2008","unstructured":"Bhandari V, Wang C, Rinder C, Rinder H. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics. 2008;121(1):129\u201334.","journal-title":"Pediatrics"},{"key":"7725_CR23","doi-asserted-by":"publisher","first-page":"202646","DOI":"10.1155\/2008\/202646","volume":"2008","author":"M Groselj-Grenc","year":"2008","unstructured":"Groselj-Grenc M, Ihan A, Derganc M. Neutrophil and monocyte CD64 and CD163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes. Mediators Inflamm. 2008;2008:202646.","journal-title":"Mediators Inflamm"},{"key":"7725_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijid.2016.06.021","volume":"49","author":"Y Dang","year":"2016","unstructured":"Dang Y, Lou J, Yan Y, Yu Y, Chen M, Sun G, Li N. The role of the neutrophil Fc\u03b3 receptor I (CD64) index in diagnosing spontaneous bacterial peritonitis in cirrhotic patients. Int J Infect Dis. 2016;49:154\u201360.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"7725_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1515\/cclm-2016-0118","volume":"55","author":"SD Xiong","year":"2017","unstructured":"Xiong SD, Pu LF, Wang HP, Hu LH, Ding YY, Li MM, Yang DD, Zhang C, Xie JX, Zhai ZM. Neutrophil CD64 Index as a superior biomarker for early diagnosis of infection in febrile patients in the hematology department. Clin Chem Lab Med. 2017;55(1):82\u201390.","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"7725_CR26","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1177\/0300060519860677","volume":"47","author":"Z Ye","year":"2019","unstructured":"Ye Z, Zou H, Liu S, Mei C, Chang X, Hu Z, Yang H, Wu Y. Diagnostic performance of neutrophil CD64 index in patients with sepsis in the intensive care unit. J Int Med Res. 2019;47(9):4303\u201311.","journal-title":"J Int Med Res"},{"issue":"12","key":"7725_CR27","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.5005\/jp-journals-10071-23558","volume":"24","author":"R Patnaik","year":"2020","unstructured":"Patnaik R, Azim A, Agarwal V. Neutrophil CD64 a diagnostic and prognostic marker of sepsis in adult critically ill patients: A brief review. Indian J Crit Care Med. 2020;24(12):1242\u201350.","journal-title":"Indian J Crit Care Med"},{"issue":"11","key":"7725_CR28","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/biomedicines8110494","volume":"8","author":"SK Hung","year":"2020","unstructured":"Hung SK, Lan HM, Han ST, Wu CC, Chen KF. Current evidence and limitation of biomarkers for detecting sepsis and systemic infection. Biomedicines. 2020;8(11):494.","journal-title":"Biomedicines"},{"issue":"1","key":"7725_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13054-015-0972-z","volume":"19","author":"X Wang","year":"2015","unstructured":"Wang X, Li ZY, Zeng L, Zhang AQ, Pan W, Gu W, Jiang JX. Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: a meta-analysis. Crit Care. 2015;19(1):245.","journal-title":"Crit Care"},{"issue":"3","key":"7725_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3855\/jidc.6532","volume":"10","author":"I Muzlovic","year":"2016","unstructured":"Muzlovic I, Ihan A, Stubljar D. CD64 index on neutrophils can diagnose sepsis and predict 30-day survival in subjects after ventilator-associated pneumonia. J Infect Dev Ctries. 2016;10(3):260\u20138.","journal-title":"J Infect Dev Ctries"},{"issue":"4","key":"7725_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/QCO.0000000000000467","volume":"31","author":"PS Fontela","year":"2018","unstructured":"Fontela PS, O\u2019Donnell S, Papenburg J. Can biomarkers improve the rational use of antibiotics? Curr Opin Infect Dis. 2018;31(4):347\u201352.","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"7725_CR32","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/cid\/cit936","volume":"58","author":"A Dimoula","year":"2014","unstructured":"Dimoula A, Pradier O, Kassengera Z, Dalcomune D, Turkan H, Vincent JL. Serial determinations of neutrophil CD64 expression for the diagnosis and monitoring of sepsis in critically ill patients. Clin Infect Dis. 2014;58(6):820\u20139.","journal-title":"Clin Infect Dis"},{"issue":"23","key":"7725_CR33","doi-asserted-by":"publisher","first-page":"13961","DOI":"10.1111\/jcmm.16004","volume":"24","author":"Q Liu","year":"2020","unstructured":"Liu Q, Gao Y, Ou Q, Xu Y, Zhou Z, Li T, Lu Y, Sun F, Zhou X, Li Y, et al. Differential expression of CD64 in patients with Mycobacterium tuberculosis infection: A potential biomarker for clinical diagnosis and prognosis. J Cell Mol Med. 2020;24(23):13961\u201372.","journal-title":"J Cell Mol Med"},{"issue":"22","key":"7725_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.21037\/atm.2017.09.21","volume":"5","author":"T Ryan","year":"2017","unstructured":"Ryan T, Coakley JD, Martin-Loeches I. Defects in innate and adaptive immunity in patients with sepsis and health care associated infection. Ann Transl Med. 2017;5(22):447.","journal-title":"Ann Transl Med"},{"issue":"3","key":"7725_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/jcm8030353","volume":"8","author":"P Hohlstein","year":"2019","unstructured":"Hohlstein P, Gussen H, Bartneck M, Warzecha KT, Roderburg C, Buendgens L, Trautwein C, Koch A, Tacke F. Prognostic relevance of altered lymphocyte subpopulations in critical illness and sepsis. J Clin Med. 2019;8(3):353.","journal-title":"J Clin Med"},{"issue":"1","key":"7725_CR36","doi-asserted-by":"publisher","first-page":"277296","DOI":"10.14336\/AD.2020.0627","volume":"12","author":"W He","year":"2021","unstructured":"He W, Xiao K, Fang M, Xie L. Immune cell number, phenotype, and function in the elderly with sepsis. Aging Dis. 2021;12(1):277296.","journal-title":"Aging Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07725-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T01:45:25Z","timestamp":1669772725000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07725-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7725"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07725-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"assertion":[{"value":"17 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The design and procedures of this study followed the guidelines of the Helsinki Declaration on human experimentation. And the Research Ethics Committee of Shanghai General Hospital approved all methods of this study, including collecting participants\u2019 peripheral blood and sputum samples. Informed consent forms had been obtained from participants or their next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"892"}}